Clinical value of aortic arch morphology in transfemoral TAVR: artificial intelligence evaluation.

Journal: International journal of surgery (London, England)
PMID:

Abstract

BACKGROUND: The impact of aortic arch (AA) morphology on the management of the procedural details and the clinical outcomes of the transfemoral artery (TF)-transcatheter aortic valve replacement (TAVR) has not been evaluated. The goal of this study was to evaluate the AA morphology of patients who had TF-TAVR using an artificial intelligence algorithm and then to evaluate its predictive value for clinical outcomes.

Authors

  • Yu Mao
    Department of Radiology, The Affiliated Hospital of Southwest Medical University, No. 23 Tai Ping Street, Luzhou, 646000, Sichuan, China.
  • Yang Liu
    Department of Computer Science, Hong Kong Baptist University, Hong Kong, China.
  • Mengen Zhai
    Department of Cardiovascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
  • Ping Jin
    Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Fangyao Chen
    Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China.
  • Yuhui Yang
    Department of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong province, PR China.
  • Guangyu Zhu
    Department of Computer Science and Statistics, University of Rhode Island, United States of America. Electronic address: guangyuzhu@uri.edu.
  • Tingting Yang
    School of Life Sciences, Nanjing University, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing 210000, China.
  • Gejun Zhang
    Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Kai Xu
    Department of Anesthesiology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huaian, China.
  • Xiaoke Shang
    Dalian Campus, Luxun Academy of Fine Arts, Dalian City, Liaoning Province, China.
  • Yuan Zhao
    Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY.
  • Buqing Ni
    Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Hongxin Li
    Department of Cardiovascular Surgery, Shandong Provincial Hospital, Jinan, Shandong, China.
  • Min Tang
    Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
  • Zhao Jian
    Department of Cardiovascular Surgery, Xinqiao Hospital, Chongqing, China.
  • Yining Yang
    School of Life Sciences, Tsinghua University, Beijing 100084, China.
  • Haibo Zhang
    Department of Radiology, the Third People's Hospital of Zhongshan, Zhongshan, Guangdong 528451, China.
  • Lai Wei
  • Jian Liu
    Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Timothée Noterdaeme
    Department of Cardiology, Hospital of Liege University, Liege, Belgium.
  • Ruediger Lange
    Département of Cardiology, Boulevard Patience et Beaujonc, Liège, Belgium.
  • Yingqiang Guo
    Department of Cardiovascular Surgery, West China Hospital, Chengdu, China.
  • Xiangbin Pan
    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Yongjian Wu
  • Jian Yang
    Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.